The Editorial addressed how to optimize pathological response assessment after neoadjuvant immunotherapy, linking clinical practice to drug development.
Optimizing pathological response assessment after neoadjuvant immunotherapy: linking clinical practice to drug development / Massi, D; Tawbi, H. - In: ANNALS OF ONCOLOGY. - ISSN 1569-8041. - ELETTRONICO. - 37:(2026), pp. 139-140. [10.1016/j.annonc.2025.12.016]
Optimizing pathological response assessment after neoadjuvant immunotherapy: linking clinical practice to drug development
Massi, D;
2026
Abstract
The Editorial addressed how to optimize pathological response assessment after neoadjuvant immunotherapy, linking clinical practice to drug development.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Massi 2026.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
229.66 kB
Formato
Adobe PDF
|
229.66 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
